BETA: Please send your feedback!
Flexion Therapeutics
FLXN:NAS
Biotechnology
$571.80mm
SMALL cap
$15.01
(0.77%)
0.20%
since start of 2019
-3.51
- 5
- 5
- 4
- 5
- —
- 5
- 4
- 1
- —
- —
- —
- 3
-
CF
-
PP
-
WC
-
DP
-
CH
-
ES
-
WS
-
CG
-
EP
-
CM
-
FL
-
GD
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 2007
Flexion Therapeutics, Inc. is a pharmaceutical company, which focuses on the development and commercialization of novel, local therapies. The firm specializes in treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA.
website
Headquarters
Executives
| Name | Title | Gender |
| Kerry A. Wentworth | Vice President-Regulatory Affairs & Quality | Female |
| Scott D. Kelley, MD | Vice President-Medical Affairs | Male |
| Patrick J. Mahaffy | Chairman | Male |
| Michael D. Clayman, MD | President, Chief Executive Officer, CFO & Director | Male |
| Neil Bodick, MD, PhD | Chief Scientific Officer | Male |
| Yamo Deniz, MD | Chief Medical Officer | Male |
| Rose Villandry | Vice President-Human Resources | Female |
| Dan Leblanc | Senior Vice President-CMC Operations | Male |
| Scott Young | Senior Director-Corporate Communications & IR | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
-
Carbon Footprint — N/A
-
Pollution Prevention — N/A
-
Water Conservation — N/A
-
Data & Privacy Protection — N/A
-
Consumer Health, Wellness & Safety — N/A
-
Employee Ownership, Satisfaction, Benefits & Pay — N/A
-
Workplace Health and Safety — N/A
-
Integrity of Corporate Governance — N/A
-
Ethical Practices — N/A
-
Usage of Conflict Materials — N/A
-
Forced Labor — N/A
-
Diversity of Corporate Leadership 3
Flexion Therapeutics - Competitors and Related Companies
How Flexion Therapeutics stacks up to its peers in the Biotechnology industry or with competing business segments.
Flexion Therapeutics
FLXN:NAS
Biotechnology
$571.80mm
SMALL cap
$15.01
(0.77%)
0.20%
since start of 2019
-3.51
INSYS Therapeutics
INSY:NAS
Biotechnology
$0
SMALL cap
$0.29
(0.00%)
-0.93%
since start of 2019
-0.09
Pacira Pharmaceuticals
PCRX:NAS
Pharmaceuticals: Other
$1.65bn
SMALL cap
$39.66
(0.81%)
-0.05%
since start of 2019
214.93
Ampio Pharmaceuticals
AMPE:ASE
Pharmaceuticals: Other
$63.99mm
MICRO cap
$0.45
(0.00%)
0.02%
since start of 2019
18.00
Johnson & Johnson
JNJ:NYS
Pharmaceuticals: Major
$337.87bn
MEGA cap
$128.02
(0.32%)
0.00%
since start of 2019
—
Pfizer
PFE:NYS
Pharmaceuticals: Major
$201.66bn
MEGA cap
$36.46
(0.00%)
-0.16%
since start of 2019
16.35